These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 20362481

  • 1. [Anal cancer and human papillomaviruses: a perspective based on the cervical cancer model].
    Monsonego J.
    Gynecol Obstet Fertil; 2010 Apr; 38(4):250-4. PubMed ID: 20362481
    [Abstract] [Full Text] [Related]

  • 2. Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study.
    Chin-Hong PV, Vittinghoff E, Cranston RD, Browne L, Buchbinder S, Colfax G, Da Costa M, Darragh T, Benet DJ, Judson F, Koblin B, Mayer KH, Palefsky JM.
    J Natl Cancer Inst; 2005 Jun 15; 97(12):896-905. PubMed ID: 15956651
    [Abstract] [Full Text] [Related]

  • 3. Human papillomavirus vaccines and anal carcinoma.
    Franceschi S, De Vuyst H.
    Curr Opin HIV AIDS; 2009 Jan 15; 4(1):57-63. PubMed ID: 19339940
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial.
    Kreimer AR, González P, Katki HA, Porras C, Schiffman M, Rodriguez AC, Solomon D, Jiménez S, Schiller JT, Lowy DR, van Doorn LJ, Struijk L, Quint W, Chen S, Wacholder S, Hildesheim A, Herrero R, CVT Vaccine Group.
    Lancet Oncol; 2011 Sep 15; 12(9):862-70. PubMed ID: 21865087
    [Abstract] [Full Text] [Related]

  • 5. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M, Benoy I, Simoens C, Bogers J, Beutels P, Depuydt C.
    Cancer Epidemiol Biomarkers Prev; 2009 Jan 15; 18(1):321-30. PubMed ID: 19124515
    [Abstract] [Full Text] [Related]

  • 6. Prevalence, incidence, and risk factors for human papillomavirus 16 seropositivity in Australian homosexual men.
    Poynten IM, Jin F, Templeton DJ, Prestage GP, Donovan B, Pawlita M, Fairley CK, Garland S, Grulich AE, Waterboer T.
    Sex Transm Dis; 2012 Sep 15; 39(9):726-32. PubMed ID: 22902671
    [Abstract] [Full Text] [Related]

  • 7. [Association between human papillomavirus infection, premalignant lesions of anal cancer, and the human immunodeficiency virus: prospective study on subjects with condylomata acuminata].
    Pera M, Sugrañes G, Ordi J, Trias M.
    Med Clin (Barc); 1999 Jun 12; 113(1):13-4. PubMed ID: 10422070
    [Abstract] [Full Text] [Related]

  • 8. On the etiology of anal squamous carcinoma.
    Frisch M.
    Dan Med Bull; 2002 Aug 12; 49(3):194-209. PubMed ID: 12238281
    [Abstract] [Full Text] [Related]

  • 9. Beyond cervical cancer: burden of other HPV-related cancers among men and women.
    Chaturvedi AK.
    J Adolesc Health; 2010 Apr 12; 46(4 Suppl):S20-6. PubMed ID: 20307840
    [Abstract] [Full Text] [Related]

  • 10. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
    Garland SM, Brotherton JM, Skinner SR, Pitts M, Saville M, Mola G, Jones RW.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M80-8. PubMed ID: 18945417
    [Abstract] [Full Text] [Related]

  • 11. Annual disease burden due to human papillomavirus 16 and 18 infections in Finland.
    Syrjänen KJ.
    Scand J Infect Dis Suppl; 2009 Aug 19; 108():2-32. PubMed ID: 19939209
    [Abstract] [Full Text] [Related]

  • 12. [The advantage of a specialized HPV clinic within the department of proctology].
    Skala K, Zufferey G, Robert-Yap J, Morel P, Roche B.
    Rev Med Suisse; 2011 Jun 22; 7(300):1348-50, 1352-3. PubMed ID: 21815534
    [Abstract] [Full Text] [Related]

  • 13. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.
    Barnabas RV, Laukkanen P, Koskela P, Kontula O, Lehtinen M, Garnett GP.
    PLoS Med; 2006 May 22; 3(5):e138. PubMed ID: 16573364
    [Abstract] [Full Text] [Related]

  • 14. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
    Hantz S, Alain S, Denis F.
    Gynecol Obstet Fertil; 2006 May 22; 34(7-8):647-55. PubMed ID: 16807045
    [Abstract] [Full Text] [Related]

  • 15. Global burden of human papillomavirus and related diseases.
    Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J, Bray F, Plummer M, Franceschi S.
    Vaccine; 2012 Nov 20; 30 Suppl 5():F12-23. PubMed ID: 23199955
    [Abstract] [Full Text] [Related]

  • 16. Human papillomavirus, cancer and vaccination.
    Heard I.
    Curr Opin HIV AIDS; 2011 Jul 20; 6(4):297-302. PubMed ID: 21519247
    [Abstract] [Full Text] [Related]

  • 17. HPV type 18 is more oncopotent than HPV16 in uterine cervical carcinogenesis although HPV16 is the prevalent type in Chennai, India.
    Berlin Grace VM.
    Indian J Cancer; 2009 Jul 20; 46(3):203-7. PubMed ID: 19574671
    [Abstract] [Full Text] [Related]

  • 18. How much cervical cancer in Australia is vaccine preventable? A meta-analysis.
    Brotherton JM.
    Vaccine; 2008 Jan 10; 26(2):250-6. PubMed ID: 18068276
    [Abstract] [Full Text] [Related]

  • 19. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
    Jenkins D.
    Gynecol Oncol; 2008 Sep 10; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
    [Abstract] [Full Text] [Related]

  • 20. Prevention of human papilloma virus-induced preneoplasia and cancer by prophylactic HPV vaccines.
    Hampl M.
    Minerva Med; 2007 Apr 10; 98(2):121-30. PubMed ID: 17519854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.